B. Braun New Ventures Revenue and Competitors
Estimated Revenue & Valuation
- B. Braun New Ventures's estimated annual revenue is currently $32M per year.
- B. Braun New Ventures's estimated revenue per employee is $380,952
Employee Data
- B. Braun New Ventures has 84 Employees.
- B. Braun New Ventures grew their employee count by 24% last year.
B. Braun New Ventures's People
Name | Title | Email/Phone |
---|
B. Braun New Ventures Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $15M | 60 | 3% | N/A | N/A |
#2 | $7.5M | 921 | 21% | N/A | N/A |
#3 | $14.7M | 43 | 59% | N/A | N/A |
#4 | $37.8M | 99 | 19% | N/A | N/A |
#5 | $55.3M | 132 | 29% | N/A | N/A |
#6 | $28.8M | 76 | 33% | N/A | N/A |
#7 | $4.7M | 18 | 20% | N/A | N/A |
#8 | $21.3M | 62 | -25% | N/A | N/A |
#9 | $32M | 84 | 24% | N/A | N/A |
#10 | $2.3M | 10 | -66% | N/A | N/A |
What Is B. Braun New Ventures?
As a Corporate Start-Up based in Freiburg, Germany, B. Braun New Ventures takes a lead role in the digital transformation of healthcare. With a young and fast-growing team, we develop solutions to automate medical procedures across various business areas. Our goal is to augment caregivers’ eyes, hands and decision making with sensors, robotics, and artificial intelligence. Our cloud platform team is focused on creating corporate-wide solutions that will drive the next generation of B. Braun’s digital products and connected devices. The technologies and products we develop create new treatment possibilities, enable sharing of clinical experience, and result in better patient care.
keywords:N/AN/A
Total Funding
84
Number of Employees
$32M
Revenue (est)
24%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $12.9M | 92 | 11% | N/A |
#2 | $24M | 117 | 21% | N/A |
#3 | $23.4M | 147 | 30% | N/A |
#4 | $32M | 161 | 26% | N/A |
#5 | $19.7M | 163 | 21% | N/A |